| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fc23b0ed9542b895d79b20d02f6f0bf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate |
2014-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d619eb81437a53e0a82178ecbcc4ee6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0876832fef5d02df49230d2cbe2e980
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9e51b127aa0fa6e94c6ba2abe06f80f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9348ae00617006399e70182cca8df84d |
| publicationDate |
2016-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20160044257-A |
| titleOfInvention |
Composition for improving blood lipid profile, or preventing or treating obesity comprising ethyl acetate fraction from Momordica charantia extract |
| abstract |
The present invention relates to a lipid-improving or anti-obesity composition comprising as an active ingredient an ethyl acetate fraction which is fractionated from an extract of Y. rats, wherein the ethyl acetate fraction of Y. japonica extract contains N-acetylcysteine (N -Acetyl-L-cysteine, and showed better lipid-lowering effect than simvastatin, which is a cholesterol-lowering agent, and also showed weight loss and anti-obesity activity. Therefore, ethyl acetate fraction of Yeoju extract May be usefully used for the prevention or treatment of obesity or blood lipid-related diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023101420-A1 |
| priorityDate |
2014-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |